Small non-coding RNA YF1: A new dawn in heart transplantation.

IF 12 1区医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Molecular Therapy Pub Date : 2025-04-02 Epub Date: 2025-03-19 DOI:10.1016/j.ymthe.2025.03.008

Amit Kumar Rai, Nedjheda Pierre, Venkata Naga Srikanth Garikipati

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

小非编码RNA YF1：心脏移植的新曙光。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Molecular Therapy 医学-生物工程与应用微生物

CiteScore

19.20

自引率

3.20%

发文量

357

审稿时长

3 months

期刊介绍： Molecular Therapy is the leading journal for research in gene transfer, vector development, stem cell manipulation, and therapeutic interventions. It covers a broad spectrum of topics including genetic and acquired disease correction, vaccine development, pre-clinical validation, safety/efficacy studies, and clinical trials. With a focus on advancing genetics, medicine, and biotechnology, Molecular Therapy publishes peer-reviewed research, reviews, and commentaries to showcase the latest advancements in the field. With an impressive impact factor of 12.4 in 2022, it continues to attract top-tier contributions.

期刊最新文献

Elevated MANF expression in β cells protects mice from streptozotocin-induced diabetes by attenuating islet stress and immunogenicity. Exogenous Photoreceptor-Specific N-Glycosylated PROM1 Rescues Retinal Degeneration in Patient and Mouse Models. LncRNA Gm16023 ameliorates hyperglycemia-exacerbated septic intestinal injury by modulating macrophage polarization via miR-377-3p/Sirt1 axis. Lipidated Interleukin-22 Reduces Body Weight And Spares Lean Mass In Mice By A Novel Gut Acting Mechanism Additive To GLP-1 Agonism. Pathogenic variants in the SMARCA1 gene cause a novel neurodevelopmental disorder.